| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |